Eye Patch Research Articles

Clinical Outcomes of Applying Therapeutic Contact Lenses and Eye Drops after Cataract Surgery

Purpose: To investigate the safety of applying therapeutic contact lenses and eye drops after cataract surgery.Methods: Immediately after cataract surgery, 947 eyes (group 1) used therapeutic contact lenses and eye drops and 914 (group 2) applied antibiotic ointment and wore a gauze eye patch for the first postoperative day. Clinical outcomes including best corrected visual acuity (BCVA), IOP, degree of anterior chamber inflammation, wound leakage, and postoperative endophthalmitis were compared in the two groups 1 day, 1 week, and 1 month after surgery.Results: There were no significant differences in the mean pre- and postoperative BCVA and IOP at 1 day, 1 week, and 1 month between groups 1 and 2. There was no difference in anterior chamber inflammation between the two groups at 1 day (p = 0.302), 1 week (p = 0.437), or 1 month (p = 0.960) after surgery. On the first postoperative day, 10 eyes in group 1 and nine eyes in group 2 had wound leakage (p = 1.000). There was no endophthalmitis in either group.Conclusions: The risk of postoperative complications in group 1 was not higher than in group 2. Therefore, wearing therapeutic contact lenses and using eye drops is a relatively safe management method after cataract surgery.

Approach to Strabismus

Strabismus is characterized by a misalignment of the eyes. A thorough history and physical examination should be performed by clinicians when strabismus is suspected. The Hirschberg, cover, cover-uncover, and alternate prism cover tests are commonly used to identify and diagnose strabismus. Strabismus usually requires a referral to an ophthalmologist. Treatment of strabismus involves eye patches, cycloplegic drops, prescription glasses, and surgery. Strabismus can result in vision loss due to amblyopia and may also cause double vision, psychosocial concerns, and impaired depth perception.

Comparison Between Heated Eye Mask and Intense Pulsed Light Treatment for Contact Lens-Related Dry Eye.

Background: Contact lens-related dry eye (CLDE) is common in contact lens (CL) wearers and can lead to ocular pain, decreased visual quality, and reduced quality of life. Objective: The purpose of this prospective, randomized, examiner masked study was to compare the effectiveness of intense pulsed light (IPL) and heated eye mask (HEM) for relieving CLDE. Methods: The final analysis included 60 patients (30 in the IPL group and 30 in the HEM group) who were using CL and had been suffering contact lens discomfort for more than a year. The IPL treatment group had two IPL treatments spaced 3 weeks apart, whereas the HEM group received HEM daily for 6 weeks (42 days). Non-invasive tear break-up time (NITBUT), tear-film lipid layer (TFLL), conjunctival fluorescein staining, meibum gland quality and expression, conjunctival redness score, ocular surface disease index (OSDI), best-corrected visual acuity, endothelial cell count, and intraocular pressure were assessed at baseline: first visit (V1), second visit (V2), and third visit (V3). Results: The mean age of the IPL group was 28.6 ± 4.3 years (16 females, 53%) and that of the HEM group was 28.6 ± 4.2 years (16 females, 53%). Mean NITBUT for the IPL group at V2 was 5.53 ± 0.77 sec (p < 0.001) and at V3 was 7.72 ± 0.88 sec (p < 0.001); the IPL group demonstrated a clinically and statistically significant improvement in mean NITBUT. In addition, the HEM group showed a clinically and statistically significant improvement in mean NITBUT at V3 (5.86 ± 0.76 sec, p < 0.001). At V3, the C-OSDI, TFLL score, and meibum gland quality and expressibility all increased considerably (p < 0.05) in both groups. Conclusions: Our results imply that IPL or HEM treatment of CLDE can be safely used to relieve symptoms of CLDE. In addition, IPL treatment is more effective in improving the general stability of the tear-film and decreasing the need for artificial tears in CLDE.

Role of multicomponent non-pharmacological nursing interventions on delirium prevention: A randomized controlled study

Multicomponent-Non-PharmacologicalNursingInterventions (Multi-Non-PharmaNIs) are evidence-based recommendations for the prevention of delirium. Purpose of this randomized controlled trial was to compare the effects of Multi-Non-PharmaNIs on delirium. The Multi-Non-PharmaNIs included orientation strategies (playing audio recordings of a non-family/family member), reading a daily newspaper, andwearing an eye patch at night. The absence/presence of delirium was assessed two times a day for three consecutive days. The patients in Group1 were made to listen to the orientation messages recorded in a non-family member's voice (10 min), was read newspaper, and wore an eye patch at night. Group2 received the same interventions as Group1, only the orientation messages were recorded in a family member's voice. The control group received standard nursing-care. There was a significant difference between 3 groups. When Group1 and Group2 were compared with the control group, it was found that there was a significant difference between Group2 and control group (p<0.05). Multi-Non-PharmaNIs were found to reduce delirium in critically ill patients.

Monocular Perception of Equidistance: The Effects of Viewing Experience and Motion-generated Information.

Using static depth information, normal observers monocularly perceived equidistance with high accuracy. With dynamic depth information and/or monocular viewing experience, they perceived with high precision. Therefore, monocular patients, who were adapted to monocular viewing, should be able to perceive equidistance and perform related tasks. This study investigated whether normal observers could accurately and precisely perceive equidistance with one eye, in different viewing environments, with various optical information and monocular viewing experience. Sixteen normally sighted observers monocularly perceived the distance (5 to 30 m) between a target and the self and replicated it either in some hallways that contained ample static monocular depth information but had a limited field of view or on a lawn that contained less depth information but had a large field of view. Participants remained stationary or walked 5 m before performing the task, as a manipulation of the availability of dynamic depth information. Eight observers wore eye patches for 3 hours before the experiment and gained monocular viewing experience, whereas the others did not. Both accuracy and precision were measured. As long as static monocular depth information was available, equidistance perception was effectively accurate, despite minute underestimation. Perception precision was improved by prior monocular walking and/or experience with monocularity. Accuracy and precision were not affected by the viewing environments. Using static and dynamic monocular depth information and/or with monocular experience, normal observers judged equidistance with reliable accuracy and precision. This implied that patients with monocular vision, who are better adapted than participants of this study, should also be able to perceive equidistance and perform distance-dependent tasks in natural viewing environments.

Окклюзионная терапия как метод улучшения зрительных функций у детей, перенесших лечение по поводу ретинобластомы

This review is devoted to occlusion therapy which is used to improve visual functions in children with retina affected by the treatment of retinoblastoma. There are listed the most used eye patch covering regimes, effectiveness and complications of such method. Overall, in most cases occlusion therapy provides improving of visual functions in this group of patients. Key words: occlusion therapy, retinoblastoma, eye patch, visual function in children.

Dry Eyes Post Laser Assisted in Situ Keratomileusis

Dry eye is one of the most common complications following laser-assisted in situ keratomileusis (LASIK), with nearly all patients experiencing some degree of postoperative dry eye symptoms. Postoperative dry eye affects approximately 50% of patients at 1 week postoperatively, 40% at 1 month, and 20%-40% at 6 months postoperatively. LASIK can cause intracorneal nerve damage, goblet cell damage caused by suction, and can cause changes in the shape of the central cornea. Dry eye diagnosis can be made using a questionnaire to determine the patient's history, examination of tear break up time, staining of the eye surface using fluorescein or lissamine green, and Schirmer's test. This reserech use Literatur Review Method. Post-LASIK dry eye complaints such as irritation, red eyes, foreign body sensation, pain, gritty, and photophobia. Management of post-LASIK dry eyes can be done by giving tear supplements, anti-inflammatory agents, ointments and eye patches, and treatment of meibomian gland dysfunction. Post-LASIK dry eye usually peaks within a few months after surgery, and then improves in most patients 6-12 months after surgery. Although dry eye signs and symptoms are most common in the immediate postoperative period and are usually only temporary, a minority of individuals experience chronic and severe dry eye

RANCANG BANGUN SENSOR BH1750 BERBASIS MIKROKONTROLLER SEBAGAI FOTOTERAPI PADA PENDERITA HIPERBILIRUBIN/BAYI KUNING

&#x0D; Phototherapy equipment is one type of physiotherapy equipment that is used to treat patients with Neonatal Jaundice. This tool works like an incandescent lamp in general, transmitting blue light directly to the baby's body which will then help reduce the amount of bilirubin that has accumulated in the baby's skin layer. born. This situation is experienced by many babies born prematurely and also babies who are breastfed late. Hyperbilirubinemia can be easily treated by the aforementioned light therapy. The light given by the tool is one type of light that is harmful to vision, so that in the process of irradiating the baby, an eye patch will be worn to protect the retina of the eye which is still in the process of being perfected. In the process, the author added a light reading feature/ photometer to measure the amount of light produced by the phototherapy device. The photometer is made by utilizing the BH1750 sensor with the function of reading light rays (any) in lux units, so that users can easily find out how many doses of light are produced in the therapy process.The measurement results from the photometer are displayed on the LCD, with the measurement of the light value in lux units of 266.67 Lux. The measurement results are stable with the irradiation distance between the lamp and the location of the sensor as much as 30 cm.

Eye protection following cataract surgery: a systematic review

ContexteOn note une grande variabilité en matière de modalités de protection oculaire postopératoire de la part des ophtalmologistes. Au nombre des modalités possibles, citons le couvre-œil rigide, le pansement oculaire, le bandage oculaire et la vision immédiate. Notre étude avait pour objectif d'examiner et de comparer les données sur les différents types de protection oculaire. MéthodesAprès avoir réalisé une revue systématique de la littérature, on a retenu les études comparatives originales qui avaient consigné les symptômes subjectifs (p. ex., sensation d'avoir un corps étranger dans l’œil, photophobie, larmoiement et douleur) et les résultats postopératoires (p. ex., le temps de rupture du film lacrymal, la meilleure acuité visuelle corrigée, etc.) après l'utilisation d'une méthode de protection oculaire. RésultatsLa revue a porté sur les données de 8 articles regroupant 598 yeux. Les études retenues examinaient le recours au bandage oculaire (n = 6), au pansement oculaire (n = 4), à la vision immédiate (n = 2) et au couvre-œil rigide (n = 1) en période postopératoire. Lors de 5 études, les patients qui ont eu un bandage oculaire ont spontanément signalé autant ou moins de symptômes – notamment la douleur (n = 3), la sensation d'avoir un corps étranger dans l’œil (n = 4), la photophobie (n = 3) et le larmoiement (n = 3) – que les patients qui ont reçu d'autres modalités de protection oculaire. Dans le cas du bandage oculaire, 3 études ont signalé un allongement du temps de rupture du film lacrymal, tandis que 1 étude a fait état d'améliorations de la cicatrisation cornéenne, comparativement à ce qui a été observé chez les sujets témoins. Deux études ont signalé un raccourcissement du temps de rupture du film lacrymal lors de l'utilisation d'un pansement oculaire, comparativement au bandage oculaire, tandis que dans une autre étude, le temps de rupture du film lacrymal était plus court lorsque les patients optaient pour une vision immédiate plutôt que pour un pansement oculaire. ConclusionsLes patients qui reçoivent un bandage oculaire après une chirurgie de la cataracte signalent nettement moins de symptômes, comparativement à ceux qui optent pour la vision immédiate. En effet, les patients préfèrent recevoir une forme de protection oculaire après l'intervention plutôt que d'opter pour la vision immédiate.

Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis.

Introduction One of the leading causes of blindness throughout the world is uveitis, which predominantly results in the feared complication of macular edema. We report the safety and efficacy of suprachoroidal injection of triamcinolone acetonide in the treatment of macular edema secondary to noninfectious uveitis. Methodology This prospective, nonrandomized interventional study was conducted at Layton Rahmatullah Benevolent Trust (LRBT) Eye Hospital, Lahore, from August 2019 till July 2020. All individuals older than 18 years, nonpregnant females with a central macular thickness of >320 µm were included. Those patients with uncontrolled diabetes, immunodeficiency, or any other disease mandating systemic corticosteroid use were excluded. All patients had a detailed ocular exam one week before the treatment, and 0.1 ml of triamcinolone acetonide 40 mg/ml was injected using a 30-G hollow needle into the suprachoroidal space. After the injection, an eye patch was applied and the patient was observed for three hours. All data were documented in a preformed proforma. ResultsA total of 30 patients were included in the study with a mean age of 38.1 ± 9.48 years. Statistically significant differences were found between central macular thickness at presentation and at one and three months of the procedure, i.e., 569.60 ± 170.396, 266.77 ± 73.127, and 208.27 ± 37.292 µm, respectively. A similar difference was observed when comparing visual acuity at baseline to visual acuity at one and three months of the procedure (p < 0.001). Conclusion The current study indicates that a single dose of suprachoroidal injection of triamcinolone acetonide for the treatment of macular edema secondary to uveitis is safe and efficacious. No rise in intraocular pressure (IOP) was observed during the study period. Significant improvements in central macular thickness and visual acuity as well as tolerability and safety of the treatment were seen in our study. Further larger-scale studies are needed to ascertain the long-term benefits of the suprachoroidal triamcinolone acetonide.

TheraPearl Eye Mask and Blephasteam for the treatment of meibomian gland dysfunction: a randomized, comparative clinical trial

Meibomian gland dysfunction (MGD) is the most common cause of dry eye disease (DED). In this study, we aimed to compare the effects of eyelid warming treatment using either TheraPearl Eye Mask (Bausch & Lomb Inc., New York, USA) or Blephasteam (Spectrum Thea Pharmaceuticals LTD, Macclesfield, UK) in a Norwegian population with mild to moderate MGD-related DED. An open label, randomized comparative trial with seventy patients (49 females, 21 males; mean age 53.6 years). Patients were randomly assigned to treatment with Blephasteam (n = 37) or TheraPearl (n = 33). All received a hyaluronic acid based artificial tear substitute (Hylo-Comod, Ursapharm, Saarbrücken, Germany). Patients were examined at baseline, and at three and six months initiation of treatment. Treatment efficacy was primarily evaluated by fluorescein breakup time (FBUT) and Ocular Surface Disease Index (OSDI) scores. Other outcome measures included ocular surface staining (OSS), Schirmer’s test, and meibomian quality and expressibility. Baseline parameter values did not differ between the groups. After six months of treatment, Blephasteam improved FBUT by 3.9 s (p < 0.01) and OSDI by 13.7 (p < 0.01), TheraPearl improved FBUT by 2.6 s (p < 0.01) and OSDI by 12.6 (p < 0.01). No difference between treatments was detected at 6 months (p = 0.11 for FBUT and p = 0.71 for OSDI), nor were there differences in the other tested parameters between the treatment groups. Blephasteam and TheraPearl are equally effective in treating mild to moderate MGD in a Norwegian population after 6-months of treatment.Clinicaltrials.gov ID: NCT03318874; Protocol ID: 2014/1983; First registration: 24/10/2017.

Management of Post-LASIK Dry Eye with Intense Pulsed Light in Combination with 0.1% Sodium Hyaluronate and Heated Eye Mask.

IntroductionLaser in situ keratomelieusis (LASIK) is one of the most frequently performed refractive treatments. Dry eye (DE) is common in patients after LASIK and can be bothersome postoperatively. Therapies such as intense pulsed light (IPL), sodium hyaluronate (SH) and heated eye mask (HEM) have been reported to improve signs and symptoms of DE .AimThe purpose of this prospective study was to evaluate and compare the effects of IPL and 0.1% SH (IPL group, 50 eyes) and IPL in combination with 0.1% SH and HEM (IPL + group, 50 eyes) in participants with persistent post-LASIK DE.MethodsThe final analysis included 100 patients (100 eyes) who had LASIK for myopic correction and had been experiencing moderate to severe DE following LASIK for over a year. Participants were randomly assigned to either the IPL group (2 IPL sessions) or IPL + group (2 IPL sessions and daily HEM for 4 weeks), and both groups continued the use of daily 0.1% SH (HYLO-COMOD®) preservative-free eye drops. Non-invasive tear break-up time (NITBUT), tear film lipid layer (TFLL), lower tear meniscus height (LTMH), meibomian gland quality (MGQ), meibomian gland expressibility (MGEx), corneal fluorescein staining (CFS), ocular surface disease index (OSDI) and artificial tear usage (ATU) survey were assessed at baseline (BL) and follow-up at 2 (F1) and 4 weeks (F2).ResultsFollowing the treatment protocol, all dry eye (DE) parameters assessed in this study improved significantly (P < 0.05) in both groups at F2 compared with their respective BL measurements. Inter-group comparison at F2 found significant differences in their NITBUT (IPL: 6.06 ± 0.59 vs. IPL +: 6.67 ± 0.86, P < 0.001), TFLL (IPL: 1.90 ± 0.65 vs. IPL +: 1.60 ± 0.64, P = 0.021), LTMH (IPL: 0.186 ± 0.053 vs. 0.204 ± 0.034, P = 0.003), MGQ (IPL: 1.48 ± 0.54 vs. IPL +: 1.26 ± 0.56, P = 0.026), MGEx (IPL: 1.62 ± 0.53 vs. IPL +: 1.44 ± 0.50, P = 0.038) and OSDI (IPL: 32.54 ± 6.85 vs. IPL +: 29.76 ± 4.74, P = 0.001), while CFS score (IPL: 4.02 ± 0.65 vs. IPL +: 3.96 ± 0.73, P = 0.652) and ATU (IPL: 1.88 ± 0.63 vs. IPL +: 1.72 ± 0.50, P = 0.159) showed no significant difference.ConclusionPost-LASIK DE signs and symptoms can be improved by combining therapies such as IPL, HEM and 0.1% SH. Increased TFLL due to a combination of IPL, 0.1% SH and HEM had a greater positive impact on the subjective and objective DE measurements in participants with persistent post-LASIK DE.

Association Between Childhood Visual Acuity and Late Adolescent Psychotic Experiences: A Prospective Birth Cohort Study.

A cross-sectional association between visual impairment and psychosis exists, but longitudinal evidence from children and young people is limited. We investigated whether childhood visual acuity was associated with subsequent psychotic experiences. Our sample was 6686 individuals from the Avon Longitudinal Study of Parents and Children (ALSPAC). We investigated whether our primary exposures, best corrected visual acuity at ages 7 and 11, were associated with psychotic experiences at ages 17 and 24. We also tested whether the following exposures at ages 7 and 11 were associated with subsequent psychotic experiences: requiring glasses, presence of any visual impairment, and between-eye visual acuity difference; and at age 7: strabismus, measures of binocular vision, history of eye patch, near vision impairment, and abnormal saccadic or pursuit eye movements. Analyses used multilevel models before and after adjusting for confounders. Odds of psychotic experiences increased with each 0.1-point deterioration in visual acuity score at age 11 (adjusted odds ratio [AOR] 1.23; 95% confidence interval [CI] 1.06–1.42), and at age 7 (AOR 1.18; 95% CI 1.00–1.40). Wearing glasses and visual impairment at age 11 were associated with psychotic experiences (AOR 1.63; 95% CI 1.21–2.19; AOR 1.64; 95% CI 1.23–2.19, respectively). There was no evidence of an association with other visual exposures. Visual acuity impairment in childhood is associated with psychotic experiences in late adolescence. Future research should aim to elucidate the nature of this association.

A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)

To determine if treatment with a photobiomodulation (PBM) device results in greater improvement in central subfield thickness (CST) than placebo in eyes with center-involved diabetic macular edema (CI-DME) and good vision. Phase 2 randomized clinical trial. Participants had CI-DME and visual acuity (VA) 20/25 or better in the study eye and were recruited from 23 clinical sites in the United States. One eye of each participant was randomly assigned 1:1 to a 670-nm light-emitting PBM eye patch or an identical device emitting broad-spectrum white light at low power. Treatment was applied for 90 seconds twice daily for 4 months. Change in CST on spectral-domain OCT at 4 months. From April 2019 to February 2020, 135 adults were randomly assigned to either PBM (n= 69) or placebo (n= 66); median age was 62 years, 37% were women, and 82% were White. The median device compliance was 92% with PBM and 95% with placebo. OCT CST increased from baseline to 4 months by a mean (SD) of 13 (53) μm in PBM eyes and 15 (57) μm in placebo eyes, with the mean difference (95% confidence interval [CI]) being-2 (-20 to 16) μm (P= 0.84). CI-DME, based on DRCR Retina Network sex- and machine-based thresholds, was present in 61 (90%) PBM eyes and 57 (86%) placebo eyes at 4 months (adjusted odds ratio [95% CI]= 1.30 (0.44-3.83); P= 0.63). VA decreased by a mean (SD) of-0.2 (5.5) letters and-0.6 (4.6) letters in the PBM and placebo groups, respectively (difference [95% CI]= 0.4 (-1.3 to 2.0) letters; P= 0.64). There were 8 adverse events possibly related to the PBM device and 2 adverse events possibly related to the placebo device. None were serious. PBM as given in this study, although safe and well-tolerated, was not found to be effective for the treatment of CI-DME in eyes with good vision.

Perceptions and practices of Australian cattle farmers for the treatment of pinkeye (infectious bovine keratoconjunctivitis)

Pinkeye or infectious bovine keratoconjunctivitis is a globally significant disease and occurs in every state of Australia. Economic loss due to pinkeye can be considerable and it is a major welfare concern, but not all cattle with the disease are treated by farmers. This study was conducted to understand the perceptions and practices of Australian farmers regarding the treatment of pinkeye: factors influencing when farmers treat pinkeye, treatments used and considered effective, and reasons for not treating. Data were gathered using a custom designed online questionnaire. Farmer responses suitable for assessment (n = 985) were analysed using descriptive analyses along with univariable and multivariable ordinal logistic regression models to evaluate the association of 15 explanatory variables with the outcome “when do you treat pinkeye?”. Results revealed three variables, farm size, times yarded and ranking of the pain caused by pinkeye, were significantly associated with the frequency of pinkeye treatment. Specifically, farmers with smaller farm sizes were more likely to treat their cattle for pinkeye more frequently. So too were those who yarded their cattle more, and those that rated pinkeye as highly painful. The most used treatments for pinkeye in Australia were pinkeye ointments (n = 861), followed by eye patches (n = 637), pinkeye spray (n = 623), fly control (n = 507), and pinkeye powder (n = 408). Over half of those who had used subconjunctival injection, pinkeye ointments, eye patches, injectable antibiotics and veterinarians rated them as highly effective treatments. Kerosene is still used by some farmers (n = 106). The most common reason for not treating pinkeye was that it was ‘too difficult to treat individuals’. These findings provide insight into the attitudes of Australian farmers to the treatment of pinkeye and should be used to improve pinkeye outcomes in cattle.

Effects of eye patches on corneal ulcer healing and weight gain in stocker steers on pasture: a randomized controlled trial.

Infectious bovine keratoconjunctivitis (IBK) is a painful ocular disease in cattle that is characterized by the presence of a corneal ulcer and production losses. A common industry practice is to cover an affected eye with a piece of cloth to reduce exposure to face flies and ultraviolet light with the goal of alleviating pain, accelerating healing, and reducing spread. To study the efficacy of eye patches in the treatment of IBK, a group of 216 clinically normal Angus crossbred steers were followed between April and August 2019 and evaluated weekly for the development of IBK. Eyes of cattle that developed IBK were enrolled with a blocked randomization scheme based on ulcer severity score to receive either an eye patch (treatment group) or no eye patch (control group). All treatment and control group animals received parenteral antimicrobial and nonsteroidal anti-inflammatory treatments and were housed in a pasture separated from the rest of the cohort for a maximum of 28 d or until clinical cure. Corneal ulcer areas were measured, and body weights were recorded twice weekly for steers in the treatment and control groups. Weights of all steers in the cohort were recorded three times during the trial period. The primary outcome, rate of corneal ulcer healing, was higher (P = 0.001) for lesions in eyes receiving an eye patch as determined by a linear mixed model that controlled for ulcer severity score at enrollment and previous IBK in the opposite eye. Median corneal ulcer healing time was 10 (IQR [Interquartile range] 7–17) d for patched eyes vs. 14 (IQR 7–21) d for unpatched eyes. In a Cox proportional hazards model adjusted for severity score at diagnosis, the hazard ratio for ulcer healing was 1.62 (95% CI: 1.02–2.56, P = 0.042) for eyes that received a patch compared to eyes that did not. Among all 216 steers in the cohort, those that were diagnosed with IBK had a numerically higher average daily gain (ADG) (0.45 [±SE 0.01] kg) vs. those that were not (0.42 [±SE 0.12] kg; P = 0.06). In enrolled steers that received a patch, the secondary outcome ADG was 0.47 (±SE 0.02) kg compared to 0.43 (±SE 0.02) kg in controls (P = 0.22). Weight gain may have been confounded by pasture during the treatment period. Results of this trial support the use of this low-cost intervention; further investigation into possible reasons for observed differences in weight gain may be warranted.

Short-Term Effects of a Novel Eye Mask Producing Heat and Vibration for the Treatment of Meibomian Gland Dysfunction: A Pilot Study.

Purpose To investigate the short-term effects on tear film parameters and ocular symptoms of a novel eye mask producing heat and vibration developed for the treatment of dry eye disease owing to meibomian gland dysfunction (MGD). Methods This is a pilot study including the first 20 consecutive patients (6 males, 14 females; mean age 52.4 ± 16.8 years) who were treated with a novel eye mask producing heat (42°) and vibration (up to 20 Hz) (Activa, SBS Sistemi, Turin, Italy) for 15 minutes. The treatment incorporates 2 phases in the following chronological order: 5 minutes of heating (phase I); 10 minutes of combination of heating and vibration (phase II). Noninvasive ocular surface examination was carried out before (T0) and 30 minutes after the mask session (T1) by means of Idra (SBS Sistemi, Turin, Italy) for the measurement of noninvasive break-up time (NIBUT) and lipid layer thickness (LLT). Patients' satisfaction after treatment was ascertained by asking the patients whether they perceived improvement from their baseline symptoms according to a 5-grade scale: none = 0; trace = 1; mild = 2; moderate = 3; high = 4. Results All patients completed regularly the mask session and no device-related adverse events were noted. NIBUT improved significantly from T0 to T1 (from 7.2 ± 1.8 s to 8.1 ± 2.1; P = 0.014). In parallel, also LLT improved from from T0 to T1 (72.5 ± 13.9 nm to 83.1 ± 16.1; P = 0.016). Seven patients (35% of the total) had a moderate satisfaction (grade 3) while 13 patients (65%) had a high satisfaction (grade 4) with treatment. Conclusions This eye mask represents a novel well tolerated tool in the armamentarium of MGD treatments. Thirty minutes after the session, NIBUT and LLT increased significantly; furthermore, all patients reported an improvement of discomfort symptoms with a moderate to high satisfaction with treatment.

Comparative Evaluation of Bandage Contact Lenses and Eye Patching after Bilateral Cataract Surgery.

Purpose To comparatively evaluate the safety and satisfaction of bandage contact lens (BCL) and eye patching in patients after cataract surgery. Methods Sixteen (32 eyes) patients who planned to undergo bilateral cataract surgery were recruited. The two eyes of each patient were randomly divided into 2 groups. Group A and Group B were instructed to wear BCLs immediately at the end of the surgery until one week and eye patch immediately after surgery until one day, respectively. Visual analog scales of ten specific symptoms, Visual Function Index (VF-14) questionnaire, and best-corrected visual acuity (BCVA) were conducted on the first day before the surgery and Day 1 and Day 7 after surgery. Oculus keratography was conducted on the first day before surgery and on Day 7. Patient satisfaction was determined on Day 1. Moreover, bacterial species in the conjunctival sac, meibomian gland secretions, and BCLs were subsequently identified using 16S rRNA gene sequencing. Results The patient satisfaction scores of Group A were higher than Group B. Group A were more motivated to choose the same treatment and were more likely to recommend BCLs to others. No statistically significant differences were found in bacterial culture positivity between the groups. The differences in ocular signs and symptoms between the two groups were not statistically significant. There were no significant differences in the BCVA and VF-14 between the groups at any time point. Conclusions BCLs could be safely and effectively used in patients after cataract surgery.

Clinical Observation of 48 Cases of Black Eye Circle Treated with Modified Yu Rong San Gel Eye Mask

Objective: To observe the clinical effect of modified Yu Rong San gel eye mask in the treatment of dark circles. Methods: 96 cases of patients with dark circles were randomly divided into treatment group and control group. In the control group and the treatment group, the common eye mask and the modified Yu Rong San gel eye mask were applied to the black circle area respectively. After 15min, water was used to wash the face, the application of the mask for one time a day, four weeks, one course, and three courses were observed. Results: After three courses of treatment, the total effective rate of the treatment group was higher than that of the control group (P&lt;0.05); the area of black eye circles in the treatment group was smaller than that before treatment (P&lt;0.05); compared with the control group, the score of black eye circles was lower than that before treatment, the difference was statistically significant (P&lt;0.05). Conclusion: Addition and reduction of Yu Rong San gel eye mask is effective in the treatment of dark circles.

RANCANG BANGUN SENSOR BH1750 BERBASIS MIKROKONTROLLER SEBAGAI FOTOTERAPI PADA PENDERITA HIPERBILIRUBIN/BAYI KUNING

Phototherapy equipment is one type of physiotherapy equipment that is used to treat patients with Neonatal Jaundice. This tool works like an incandescent lamp in general, transmitting blue light directly to the baby's body which will then help reduce the amount of bilirubin that has accumulated in the baby's skin layer. born. This situation is experienced by many babies born prematurely and also babies who are breastfed late. Hyperbilirubinemia can be easily treated by the aforementioned light therapy. The light given by the tool is one type of light that is harmful to vision, so that in the process of irradiating the baby, an eye patch will be worn to protect the retina of the eye which is still in the process of being perfected. In the process, the author added a light reading feature/ photometer to measure the amount of light produced by the phototherapy device. The photometer is made by utilizing the BH1750 sensor with the function of reading light rays (any) in lux units, so that users can easily find out how many doses of light are produced in the therapy process.The measurement results from the photometer are displayed on the LCD, with the measurement of the light value in lux units of 266.67 Lux. The measurement results are stable with the irradiation distance between the lamp and the location of the sensor as much as 30 cm.